scholarly article | Q13442814 |
P356 | DOI | 10.1080/09674845.2016.1173333 |
P8608 | Fatcat ID | release_ky5btpujofbrdc755ubtvrxwle |
P698 | PubMed publication ID | 27181171 |
P50 | author | Karli Sreenivasulu | Q89123413 |
P2093 | author name string | Lalgudi N Dorairajan | |
Hanumanthappa Nandeesha | |||
Aneena Eldhose | |||
S Arul Vijaya Vani | |||
P2860 | cites work | Molecular aspects of thyroid hormone actions | Q22306217 |
Transcriptional regulation by nonclassical action of thyroid hormone | Q28245384 | ||
Benign prostatic hyperplasia: an overview | Q33545587 | ||
The relation of serum parathyroid hormone and serum calcium to serum levels of prostate-specific antigen: a population-based study | Q33810503 | ||
Circulating thyroxine, thyroid-stimulating hormone, and hypothyroid status and the risk of prostate cancer | Q34464583 | ||
Prostate cancer, serum parathyroid hormone, and the progression of skeletal metastases | Q37113131 | ||
Thyroid hormone as a regulator of tumor induced angiogenesis | Q37823747 | ||
Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes. | Q38323028 | ||
Cell growth effects of triiodothyronine and expression of thyroid hormone receptor in prostate carcinoma cells. | Q40428033 | ||
Association between serum triiodothyronine (t3) level and risk of disease recurrence in men with localized prostate cancer | Q46779518 | ||
Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia | Q46974672 | ||
P433 | issue | 2 | |
P304 | page(s) | 94-96 | |
P577 | publication date | 2016-04-28 | |
P1433 | published in | British Journal of Biomedical Science | Q15750949 |
P1476 | title | Thyroid and parathyroid hormones in benign prostatic hyperplasia | |
P478 | volume | 73 |
Q39138486 | British Journal of Biomedical Science in 2016. What have we learned? | cites work | P2860 |